Literature DB >> 2403399

Structural characterization of the second major cross-reactive idiotype group of human rheumatoid factors. Association with the VH4 gene family.

G J Silverman1, R E Schrohenloher, M A Accavitti, W J Koopman, D A Carson.   

Abstract

Rheumatoid factors (RF) are the most common type of functional antibodies among naturally occurring human monoclonal IgM proteins. A large subset of these autoantibodies use structurally homologous light chains of the kappa III subgroup, which bear the 6B6.6 cross-reactive idiotype (CRI). Although antibody binding activity requires both heavy and light chains, information about the heavy chains used by these autoantibodies is limited. To investigate these proteins, the murine monoclonal antibodies, 5-14 and 6-10, were generated by immunization with the heavy chains of the 6B6.6 CRI-positive RF, COR and LEW. These antiidiotypic antibodies reacted with 8 of 11 autoantibodies that coexpressed the 6B6.6 CRI. All 8 RF had heavy chains from the VH4 gene family, as assessed by reactivity with a VH4-specific primary sequence-dependent antibody. The same RF were also identified by the previously described murine monoclonal antiidiotype, LC1. Further experiments revealed that the LC1 antibody delineates a subfamily of VH4 heavy chains that is preferentially used in kappa III-6B6.6 CRI-positive IgM-RF. The cumulative data suggest that 13-22% of RF express both the kappa III-6B6.6 and VH4-LC1 CRI. These findings document that RF autoantibody activity requires specific VL-VH pairing, and that a subset of idiotypically related VH4 heavy chains is commonly expressed in disease-associated monoclonal IgM-RF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403399     DOI: 10.1002/art.1780330907

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Superantigen properties of a human sialoprotein involved in gut-associated immunity.

Authors:  G J Silverman; P Roben; J P Bouvet; M Sasano
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 5.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.

Authors:  A E Pugh-Bernard; G J Silverman; A J Cappione; M E Villano; D H Ryan; R A Insel; I Sanz
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated.

Authors:  K Youngblood; L Fruchter; G Ding; J Lopez; V Bonagura; A Davidson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains.

Authors:  G J Silverman; A H Lucas
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.

Authors:  C M Brown; C Longhurst; G Haynes; C Plater-Zyberk; A Malcolm; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

10.  Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas.

Authors:  L Diaw; D Siwarski; A Coleman; J Kim; G M Jones; G Dighiero; K Huppi
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.